Výsledky vyhledávání - "van Hoogstraten HJ"

Akademický článek

A randomized controlled trial evaluating therapy with ursodeoxycholic acid in daily doses of 10 mg/kg versus 20 mg/kg in primary biliary cirrhosis.

Autor: van Hoogstraten, HJ. F., de Smet, M. B.M., Renooij, W., Hop, W. C.J., van Berge-Henegouwen, G. P., Schalm, S. W., van Buuren, H. R.

Publikováno v: European Journal of Gastroenterology & Hepatology; Dec1998, Vol. 10 Issue 12, pA7-A7, 1p

Zobrazit plný text záznamu

Akademický článek

Combination therapy with infliximab and azathioprine is superior to monotherapy with either agent in ulcerative colitis.

Autor: Panaccione R, Ghosh S, Middleton S, Márquez JR, Scott BB, Flint L, van Hoogstraten HJ, Chen AC, Zheng H, Danese S, Rutgeerts P

Publikováno v: Gastroenterology [Gastroenterology] 2014 Feb; Vol. 146 (2), pp. 392-400.e3.

Zobrazit plný text záznamu

Akademický článek

Efficacy and safety of infliximab as continuous or intermittent therapy in patients with moderate-to-severe plaque psoriasis: results of a randomized, long-term extension trial (RESTORE2).

Autor: Reich K; Dermatologikum Hamburg, Drehbahn 1-3 20354, Hamburg, Germany. kreich@dermatologikum.de, Wozel G, Zheng H, van Hoogstraten HJ, Flint L, Barker J

Publikováno v: The British journal of dermatology [Br J Dermatol] 2013 Jun; Vol. 168 (6), pp. 1325-34.

Zobrazit plný text záznamu

Akademický článek

Budesonide or prednisone in combination with ursodeoxycholic acid in primary sclerosing cholangitis: a randomized double-blind pilot study. Belgian-Dutch PSC Study Group.

Autor: van Hoogstraten HJ; Department of Hepatogastroenterology, University Hospital Rotterdam, The Netherlands., Vleggaar FP, Boland GJ, van Steenbergen W, Griffioen P, Hop WC, van Hattum J, van Berge Henegouwen GP, Schalm SW, van Buuren HR

Publikováno v: The American journal of gastroenterology [Am J Gastroenterol] 2000 Aug; Vol. 95 (8), pp. 2015-22.

Zobrazit plný text záznamu

Report

The unusual patient with advanced renal insufficiency on ACE inhibitors.

Autor: van Hoogstraten HJ, van der Sluijs JP, van der Meulen J

Publikováno v: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association [Nephrol Dial Transplant] 2000 Jan; Vol. 15 (1), pp. 130.

Zobrazit plný text záznamu

Akademický článek

Prognostic factors and long-term effects of ursodeoxycholic acid on liver biochemical parameters in patients with primary biliary cirrhosis. Dutch Multi-Centre PBC Study Group.

Autor: van Hoogstraten HJ; Department of Hepatogastroenterology, Erasmus University Hospital Rotterdam, The Netherlands., Hansen BE, van Buuren HR, ten Kate FJ, van Berge-Henegouwen GP, Schalm SW

Publikováno v: Journal of hepatology [J Hepatol] 1999 Aug; Vol. 31 (2), pp. 256-62.

Zobrazit plný text záznamu

Akademický článek

Triple therapy with ursodeoxycholic acid, prednisone and azathioprine in primary biliary cirrhosis: a 1-year randomized, placebo-controlled study.

Autor: Wolfhagen FH; Department of Hepatogastroenterology, University Hospital Rotterdam, The Netherlands., van Hoogstraten HJ, van Buuren HR, van Berge-Henegouwen GP, ten Kate FJ, Hop WC, van der Hoek EW, Kerbert MJ, van Lijf HH, den Ouden JW, Smit AM, de Vries RA, van Zanten RA, Schalm SW

Publikováno v: Journal of hepatology [J Hepatol] 1998 Nov; Vol. 29 (5), pp. 736-42.

Zobrazit plný text záznamu

Akademický článek

A randomized trial in primary biliary cirrhosis comparing ursodeoxycholic acid in daily doses of either 10 mg/kg or 20 mg/kg. Dutch Multicentre PBC Study Group.

Autor: Van Hoogstraten HJ; Department of Hepatogastroenterology, University Hospital Rotterdam, The Netherlands., De Smet MB, Renooij W, Breed JG, Engels LG, Den Ouden-Muller JW, Rijk MC, Smit AM, Zwertbroek R, Hop WC, van Berge Henegouwen GP, Schalm SW, van Buuren HR

Publikováno v: Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 1998 Oct; Vol. 12 (10), pp. 965-71.

Zobrazit plný text záznamu

Plný text ve formátu HTML

Akademický článek

Ursodeoxycholic acid therapy for primary sclerosing cholangitis: results of a 2-year randomized controlled trial to evaluate single versus multiple daily doses.

Autor: van Hoogstraten HJ; Erasmus University Hospital Rotterdam, The Netherlands., Wolfhagen FH, van de Meeberg PC, Kuiper H, Nix GA, Becx MC, Hoek AC, van Houte DP, Rijk MC, Salemans JM, Scherpenisse J, Schrijver M, Smit AM, Spoelstra P, Stadhouders PH, Tan TG, Hop WC, ten Kate FJ, vanBerge-Henegouwen GP, Schalm SW, van Buuren HR

Publikováno v: Journal of hepatology [J Hepatol] 1998 Sep; Vol. 29 (3), pp. 417-23.

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání